These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25288403)

  • 1. Identification of novel RHPS4-derivative ligands with improved toxicological profiles and telomere-targeting activities.
    Rizzo A; Iachettini S; Zizza P; Cingolani C; Porru M; Artuso S; Stevens M; Hummersone M; Biroccio A; Salvati E; Leonetti C
    J Exp Clin Cancer Res; 2014 Oct; 33(1):81. PubMed ID: 25288403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On and off-target effects of telomere uncapping G-quadruplex selective ligands based on pentacyclic acridinium salts.
    Iachettini S; Stevens MF; Frigerio M; Hummersone MG; Hutchinson I; Garner TP; Searle MS; Wilson DW; Munde M; Nanjunda R; D'Angelo C; Zizza P; Rizzo A; Cingolani C; De Cicco F; Porru M; D'Incalci M; Leonetti C; Biroccio A; Salvati E
    J Exp Clin Cancer Res; 2013 Sep; 32(1):68. PubMed ID: 24330541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
    Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
    Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological activity of the G-quadruplex ligand RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) is associated with telomere capping alteration.
    Leonetti C; Amodei S; D'Angelo C; Rizzo A; Benassi B; Antonelli A; Elli R; Stevens MF; D'Incalci M; Zupi G; Biroccio A
    Mol Pharmacol; 2004 Nov; 66(5):1138-46. PubMed ID: 15304549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism.
    Phatak P; Cookson JC; Dai F; Smith V; Gartenhaus RB; Stevens MF; Burger AM
    Br J Cancer; 2007 Apr; 96(8):1223-33. PubMed ID: 17406367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy.
    Salvati E; Scarsella M; Porru M; Rizzo A; Iachettini S; Tentori L; Graziani G; D'Incalci M; Stevens MF; Orlandi A; Passeri D; Gilson E; Zupi G; Leonetti C; Biroccio A
    Oncogene; 2010 Nov; 29(47):6280-93. PubMed ID: 20802516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RHPS4 G-quadruplex ligand induces anti-proliferative effects in brain tumor cells.
    Lagah S; Tan IL; Radhakrishnan P; Hirst RA; Ward JH; O'Callaghan C; Smith SJ; Stevens MF; Grundy RG; Rahman R
    PLoS One; 2014; 9(1):e86187. PubMed ID: 24454961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of quadruplex DNA perturbs telomere replication leading to the activation of an ATR-dependent ATM signaling pathway.
    Rizzo A; Salvati E; Porru M; D'Angelo C; Stevens MF; D'Incalci M; Leonetti C; Gilson E; Zupi G; Biroccio A
    Nucleic Acids Res; 2009 Sep; 37(16):5353-64. PubMed ID: 19596811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes.
    Musumeci D; Amato J; Zizza P; Platella C; Cosconati S; Cingolani C; Biroccio A; Novellino E; Randazzo A; Giancola C; Pagano B; Montesarchio D
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1341-1352. PubMed ID: 28130159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor polycyclic acridines. 20. Search for DNA quadruplex binding selectivity in a series of 8,13-dimethylquino[4,3,2-kl]acridinium salts: telomere-targeted agents.
    Cheng MK; Modi C; Cookson JC; Hutchinson I; Heald RA; McCarroll AJ; Missailidis S; Tanious F; Wilson WD; Mergny JL; Laughton CA; Stevens MF
    J Med Chem; 2008 Feb; 51(4):963-75. PubMed ID: 18247546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic strategies to a telomere-targeted pentacyclic heteroaromatic salt.
    Hutchinson I; Stevens MF
    Org Biomol Chem; 2007 Jan; 5(1):114-20. PubMed ID: 17164914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of a telomere destabilizing agent on cancer cell-cycle dynamics--integrated modelling and experiments.
    Hirt BV; Wattis JA; Preston SP; Laughton CA
    J Theor Biol; 2012 Feb; 295():9-22. PubMed ID: 22108242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage persistence as determinant of tumor sensitivity to the combination of Topo I inhibitors and telomere-targeting agents.
    Biroccio A; Porru M; Rizzo A; Salvati E; D'Angelo C; Orlandi A; Passeri D; Franceschin M; Stevens MF; Gilson E; Beretta G; Zupi G; Pisano C; Zunino F; Leonetti C
    Clin Cancer Res; 2011 Apr; 17(8):2227-36. PubMed ID: 21355072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor polycyclic acridines. 8.(1) Synthesis and telomerase-inhibitory activity of methylated pentacyclic acridinium salts.
    Heald RA; Modi C; Cookson JC; Hutchinson I; Laughton CA; Gowan SM; Kelland LR; Stevens MF
    J Med Chem; 2002 Jan; 45(3):590-7. PubMed ID: 11806711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-quadruplex ligand RHPS4 potentiates the antitumor activity of camptothecins in preclinical models of solid tumors.
    Leonetti C; Scarsella M; Riggio G; Rizzo A; Salvati E; D'Incalci M; Staszewsky L; Frapolli R; Stevens MF; Stoppacciaro A; Mottolese M; Antoniani B; Gilson E; Zupi G; Biroccio A
    Clin Cancer Res; 2008 Nov; 14(22):7284-91. PubMed ID: 19010844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrative biological approach to the analysis of tissue culture data: application to the antitumour agent RHPS4.
    Johnson LA; Byrne HM; Willis AE; Laughton CA
    Integr Biol (Camb); 2011 Aug; 3(8):843-9. PubMed ID: 21773618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naphthalene diimide-derivatives G-quadruplex ligands induce cell proliferation inhibition, mild telomeric dysfunction and cell cycle perturbation in U251MG glioma cells.
    Muoio D; Berardinelli F; Leone S; Coluzzi E; di Masi A; Doria F; Freccero M; Sgura A; Folini M; Antoccia A
    FEBS J; 2018 Oct; 285(20):3769-3785. PubMed ID: 30095224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMICORON: A multi-targeting G4 ligand with a promising preclinical profile.
    Porru M; Zizza P; Franceschin M; Leonetti C; Biroccio A
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1362-1370. PubMed ID: 27838395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes.
    Gowan SM; Heald R; Stevens MF; Kelland LR
    Mol Pharmacol; 2001 Nov; 60(5):981-8. PubMed ID: 11641426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect.
    Salvati E; Leonetti C; Rizzo A; Scarsella M; Mottolese M; Galati R; Sperduti I; Stevens MF; D'Incalci M; Blasco M; Chiorino G; Bauwens S; Horard B; Gilson E; Stoppacciaro A; Zupi G; Biroccio A
    J Clin Invest; 2007 Nov; 117(11):3236-47. PubMed ID: 17932567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.